Table 2.
Comparison of healthcare utilization and costs in patients with schizophrenia
Days and costs | Pre-PP period | Post-PP period | t | p value |
---|---|---|---|---|
Outpatient (n = 1,272) | ||||
The number of days | 199.06 ± 134.03 | 332.51 ± 59.30 | −33.94 | < 0.0001 |
Total costs (USD) | 1,505.22 ± 1,353.27 | 3,002.37 ± 1,217.12 | −34.78 | < 0.0001 |
Admission (n = 423) | ||||
The number of days | 54.30 ± 61.93 | 29.75 ± 60.63 | 5.56 | < 0.0001 |
Total costs (USD) | 2,969.53 ± 3,587.37 | 1,748.78 ± 3,639.64 | 4.82 | < 0.0001 |
Values are presented as mean ± standard deviation.
PP, paliperidone palmitate long-acting injection; Pre-PP, the 1-year period before the initiation of PP; Post-PP, the 1-year period after the initiation of PP; USD, United States dollar.